Market Overview:
Recombinant proteins are substances used in production of novel therapies for severe chronic diseases such as cancer and other rare diseases. They are classified into hormones, recombinant metabolic enzymes, growth factor, plasma protein factor, cytokines, and others.
Growing research &development activities on biologic drugs for life threatening disease such as cancer is expected to augment recombinant protein market. According to the International Agency for Research on Cancer, worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020.
Advent of advanced technology for producing recombinant protein is again driving growth of the market. For instance, in June 2020, Lonza has expanded its cell culture media portfolio with the addition of the GSv9™ Media and Feeds, providing a fully integrated solution specifically designed to optimize recombinant protein production using Lonza’s GS Gene Expression System®.
Get PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/1516
Covid-19 Impact Analysis
The outbreak of Covid-19 has impacted the entire supply chain of the biotechnology industry due to travel restriction. This has disrupted the supply of raw materials for production of recombinant protein.
Competitive Landscape:
Crown Bioscience, Inc., ProSpec Tany TechnoGene, Ltd., BPS Bioscience, Inc., Sigma Aldrich Company Ltd., Novoprotein Scientific, PeproTech, Inc., Feldan Bio, Inc., BioVision, Inc., HumanZyme, Inc., and GenScript Biotech Corporation
Key Takeaways:
The recombinant protein market is expected to exhibit a CAGR of 6.2% over the forecast period owing to the Increasing research & development expenditure on biologic drugs.
North America is expected to gain significant growth over the forecast period owing to the high prevalence of chronic disease. According to the Centers for Disease Control and Prevention, chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the United States. They are also leading drivers of the nation’s $3.8 trillion in annual health care costs
Reasons to Buy this Recombinant Protein Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Recombinant Protein market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Recombinant Protein market
➡Leading company profiles reveal details of key Recombinant Protein market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Recombinant Protein market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report With Flat USD 2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1516
Table of Content
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- PEST Analysis
- PORTER’s Analysis
- Market Dynamics
- Global Recombinant Protein Market, By Product Type, 2015–2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Hormones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Growth Factor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Cytokines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Plasma Protein Factor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Recombinant Metabolic Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Immune Checkpoint Regulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Introduction
- Global Recombinant Protein Market, By Application, 2015–2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Biopharmaceutical Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Basic Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Introduction
- Global Recombinant Protein Market, By End User, 2015–2025 (US$ Mn)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016–2025
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
- Introduction
- Global Recombinant Protein Market, By Region, 2015–2025 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, For Regions, 2016–2025
- North America
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of APAC
- Latin America
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Application, 2015–2025 (US$ Mn)
- Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Crown Bioscience, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ProSpec Tany TechnoGene, Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BPS Bioscience, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sigma Aldrich Company Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novoprotein Scientific
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PeproTech, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Feldan Bio, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioVision, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HumanZyme, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript Biotech Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Crown Bioscience, Inc.
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837